Aalto Bio Reagents Launches World's First Commercially Available
Venezuela Equine Encephalitis Virus (VEEV) Protein.
BARCELONA, SPAIN, JUNE 6, 2019 — On the occasion of the 11th International Global Virus
Network meeting, Aalto Bio Reagents launches the first commercially available protein for the
detection and diagnosis of Venezuela Equine Encephalitis NSP2 TC83.
Read The Full Press Release here